Under partnership, the U.K. drugmaker will sell Zhifei $3 billion of its Shingrix vaccine for distribution across China

A county-level jurisdiction in Inner Mongolia has begun inoculating almost 10,000 schoolgirls between 13 and 18 years old against the cancer-causing virus

British giant has struggled to sell HPV vaccines in China amid stiff competition, but CEO remains upbeat

Shares of Zai Lab sag after company halts trials for eczema treatment

Green light shows drug regulator has recognized China’s urgent need for Gardasil 9

Gardasil 9 protects against more strains of sexually transmitted virus that can cause cancer

Triumeq, produced by GSK-controlled ViiV Healthcare, brought in $2.2 billion in 2016 worldwide

GlaxoSmithKline’s vaccine sales outpace average sales growth, while Eli Lilly’s revenue from insulin drug plunges

19 current, former employees freed after serving brief sentences for aggressive tactics to lure gamblers to its casinos

U.K. drugmaker gets inoculation for key cause of cervical cancer to mainland ahead of Merck, which controlled 94% of market in 2016

Global drugmakers agree to reduce prices to get 36 drugs on China’s partial-reimbursement list

Green light comes year after rival GlaxoSmithKline obtained approval of similar product in the country